Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular and cell biology of primary hyperoxaluria type 1.

× No keyword cloud information.

9 in total

1. Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1.

Authors: P E Purdue; Y Takada; C J Danpure
Journal: J Cell Biol Date: 1990-12 Impact factor: 10.539

2. Molecular characterization and clinical use of a polymorphic tandem repeat in an intron of the human alanine:glyoxylate aminotransferase gene.

Authors: C J Danpure; G M Birdsey; G Rumsby; M J Lumb; P E Purdue; J Allsop
Journal: Hum Genet Date: 1994-07 Impact factor: 4.132

Review 3. Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity.

Authors: C J Danpure; P R Jennings; P Fryer; P E Purdue; J Allsop
Journal: J Inherit Metab Dis Date: 1994 Impact factor: 4.982

4. Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation.

Authors: C J Danpure; P E Purdue; P Fryer; S Griffiths; J Allsop; M J Lumb; K M Guttridge; P R Jennings; J I Scheinman; S M Mauer
Journal: Am J Hum Genet Date: 1993-08 Impact factor: 11.025

5. A glycine-to-glutamate substitution abolishes alanine:glyoxylate aminotransferase catalytic activity in a subset of patients with primary hyperoxaluria type 1.

Authors: P E Purdue; M J Lumb; J Allsop; Y Minatogawa; C J Danpure
Journal: Genomics Date: 1992-05 Impact factor: 5.736

6. An intronic duplication in the alanine: glyoxylate aminotransferase gene facilitates identification of mutations in compound heterozygote patients with primary hyperoxaluria type 1.

Authors: P E Purdue; M J Lumb; J Allsop; C J Danpure
Journal: Hum Genet Date: 1991-08 Impact factor: 4.132

7. A serine-to-phenylalanine substitution leads to loss of alanine:glyoxylate aminotransferase catalytic activity and immunoreactivity in a patient with primary hyperoxaluria type 1.

Authors: Y Minatogawa; S Tone; J Allsop; P E Purdue; Y Takada; C J Danpur; R Kido
Journal: Hum Mol Genet Date: 1992-11 Impact factor: 6.150

8. An enzyme trafficking defect in two patients with primary hyperoxaluria type 1: peroxisomal alanine/glyoxylate aminotransferase rerouted to mitochondria.

Authors: C J Danpure; P J Cooper; P J Wise; P R Jennings
Journal: J Cell Biol Date: 1989-04 Impact factor: 10.539

9. ATP-dependent degradation of a mutant serine: pyruvate/alanine:glyoxylate aminotransferase in a primary hyperoxaluria type 1 case.

Authors: K Nishiyama; T Funai; S Yokota; A Ichiyama
Journal: J Cell Biol Date: 1993-12 Impact factor: 10.539

9 in total

3 in total

Review 1. Oxalate crystal deposition disease.

Authors: Irama Maldonado; Vineet Prasad; Antonio J Reginato
Journal: Curr Rheumatol Rep Date: 2002-06 Impact factor: 4.592

2. Skeletal features of primary hyperoxaluria type 1, revisited.

Authors: Samer El Hage; Ismat Ghanem; André Baradhi; Chebel Mourani; Samir Mallat; Fernand Dagher; Khalil Kharrat
Journal: J Child Orthop Date: 2008-02-15 Impact factor: 1.548

3. High throughput cell-based assay for identification of glycolate oxidase inhibitors as a potential treatment for Primary Hyperoxaluria Type 1.

Authors: Mengqiao Wang; Miao Xu; Yan Long; Sonia Fargue; Noel Southall; Xin Hu; John C McKew; Christopher J Danpure; Wei Zheng
Journal: Sci Rep Date: 2016-09-27 Impact factor: 4.379

3 in total